课题基金 / 基金详情

DISRUPTIVE TECHNOLOGY FOR KINETIC STUDIES OF PROTEIN-SMALL MOLECULE BINDING

DISRUPTIVE TECHNOLOGY FOR KINETIC STUDIES OF PROTEIN-SMALL MOLECULE BINDING
蛋白质-小分子结合动力学研究的颠覆性技术
批准号:
RTI-2017-00405
负责人:
Krylov, Sergey
金额:
$10.83万
依托单位:
依托单位国家:
加拿大
项目类别:
Research Tools and Instruments
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-01-01 至 2017-12-31

项目摘要

项目成果

Krylov, Sergey的其他基金

相似基金

相关文献

中文摘要
翻译
可逆的蛋白质-小分子结合的动力学研究对于理解疾病的分子机制以及发展分子诊断和药物先导是至关重要的。基于生物传感器的方法大多建立在这类研究中,但它们需要将蛋白质或小分子固定在传感器上。固定化通常会阻止结合。在这里,我们提出了一种设备,它将独特地实现蛋白质-小分子结合的无固定化动力学研究。 在为期3年的技术开发阶段,我们的两个实验室(37个总部基地和大约80万美元/年的运营资金)将使用拟议的仪器。在这一阶段,我们将:(I)组装一台独特的非固定化动力学研究仪器,(Ii)开发快速准确的信号处理和数据分析算法,(Iii)使用由尤丁实验室和GSK(工业合作者)创建的库中研究小分子结合动力学的仪器,(Iv)设计该仪器和软件的商业版本,(V)启动该技术的商业化,以及(Vi)设计和实施供HQP使用该仪器的培训方案。 在技术开发阶段之后,该仪器将被放置在约克生物分析核心设施(YBioCore)。然后,它将被来自10个实验室的训练有素的HQP使用,这些实验室在约克进行相关研究。外部用户也可以访问它。克里洛夫的实验室将每年为HQP举办为期3天的研讨会。工作坊将包括课程和动手练习。仪器将由设施技术人员维护,但由训练有素的HQP操作。具有这种技能的HQP是制药和生物技术行业非常需要的。 在YBioCore,该仪器将供研究疾病分子机制的生物学家和开发诊断探针和药物线索的化学家使用。该仪器的独特能力将有助于获得动力学数据,而没有该仪器将很难或不可能获得这些数据。利用该仪器获得的数据将使分子诊断和药物线索的开发成为可能,这反过来又将使加拿大人受益。 如果我们不能在2017年建造拟议的仪器,我们实验室的两个重要方向实际上将停滞不前。在Krylov的实验室里,这是基于LSTDLPF的技术的开发,目前由3个PDF和2个研究生进行。在尤丁的实验室里,这是一项大周期-蛋白质结合研究,目前由4名研究生进行。因此,延迟获取该仪器将大大推迟6名研究生完成学位要求和3名PDF的职业培训。拖延获得该工具也将产生更广泛的影响,因为它还将推迟将我们高度有利的技术转让给为其开发这项技术的广大学术和工业最终用户社区。
英文摘要
Kinetic studies of reversible protein-small molecule binding are pivotal to understanding molecular mechanisms of diseases and development of molecular diagnostics and drug leads. Biosensor-based methods are most established in such studies, but they require the immobilization of either protein or small molecule on the sensor. The immobilization often blocks the binding. Here we propose equipment that will uniquely enable immobilization-free kinetic studies of protein-small molecule binding. The proposed instrument will be used by our 2 labs (37 HQP and ~$0.8M/year operating funds) during a 3-year technology-development stage. During this stage, we will: (i) assemble a unique instrument for immobilization-free kinetic studies, (ii) develop algorithms for fast and accurate signal processing and data analysis, (iii) use the instrument for studying binding kinetics for small molecules from libraries generated by Yudin’s lab and GSK (industrial collaborator), (iv) design commercial versions of the instrument and software, (v) initiate commercialization of the technology, and (vi) design and implement a training protocol for use of the instrument by HQP. After the technology-development stage, the instrument will be placed in the York Bioanalytical Core Facility (YBioCore). It will then be used by trained HQP from 10 labs carrying out relevant research at York. It will also be accessible to external users. Krylov’s lab will hold annual 3-day workshops for HQP. The workshops will include classes as well as hands-on exercises. The instrument will be maintained by Facility technical staff but operated by trained HQP. HQP with such skills are highly desired by the pharma and biotech industries. When in YBioCore, the instrument will be used by biologists studying molecular mechanisms of diseases and chemists developing diagnostic probes and drug leads. The unique capabilities of the instrument will facilitate obtaining kinetic data that would be difficult or impossible without this instrument. The data obtained with the instrument will enable the development of molecular diagnostics and drug leads which, in turn, will benefit Canadians. If we are not able to build the proposed instrument in 2017, 2 important directions in our labs will be practically stalled. In Krylov’s lab it is the development of the LSTDLPF-based technology, which is currently carried out by 3 PDFs and 2 grad students. In Yudin’s lab, it is macrocycle-protein binding studies, which are currently run by 4 grad students. A delay in acquiring the instrument will, thus, significantly delay the completion of degree requirements by 6 grad students and the career training of 3 PDFs. A delay in obtaining the instrument will also have a much wider impact as it will also delay the transfer of our highly-enabling technology to a broad community of academic and industrial end-users for whom this technology is being developed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADVANCING INSTRUMENTAL BIOANALYTICAL MATHODS
  • 批准号:
    RTI-2023-00427
  • 项目类别:
    Research Tools and Instruments
  • 资助金额:
    $10.89万
  • 财政年份:
    2022
  • 负责人:
    Krylov, Sergey
  • 依托单位:
Disruptive Analytical Technologies for Biomedical Sciences
  • 批准号:
    RGPIN-2022-04563
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $8.81万
  • 财政年份:
    2022
  • 负责人:
    Krylov, Sergey
  • 依托单位:
NOVEL ANALYTICAL TOOLS FOR BIOLOGY AND MEDICINE
  • 批准号:
    RGPIN-2016-05312
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $6.63万
  • 财政年份:
    2021
  • 负责人:
    Krylov, Sergey
  • 依托单位:
NOVEL ANALYTICAL TOOLS FOR BIOLOGY AND MEDICINE
  • 批准号:
    RGPIN-2016-05312
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $6.63万
  • 财政年份:
    2020
  • 负责人:
    Krylov, Sergey
  • 依托单位:
国内基金
海外基金
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    USHARANI HAREESH GOVINDARA JAN
  • 依托单位:
Capture and Release of Droplets Using Advanced Materials for High Technology Applications
  • 批准号:
    52073127
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    Alidad Amirfazli
  • 依托单位:
Journal of Computer Science and Technology
  • 批准号:
    61224001
  • 项目类别:
    专项基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2012
  • 负责人:
    万晓霰
  • 依托单位:
Journal of Materials Science & Technology
  • 批准号:
    51024801
  • 项目类别:
    专项基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2010
  • 负责人:
    罗东
  • 依托单位: